# Diagnostics Sector

Canonical URL: https://biopharmsignal.com/sector/diagnostics

Diagnostics is a company sector tag on BioPharmSignal. This page groups public biotech and healthcare companies associated with Diagnostics, making it easier to scan related businesses, compare peers, and follow companies exposed to the same modality, disease area, or development theme.

Companies currently grouped under Diagnostics: 38

## Recent Sector News

- 2026-09-03 20:30 EST — BIAF — [bioAffinity Technologies to Participate in the H.C. Wainwright 28th Annual Global Investment Conference](https://biopharmsignal.com/news/BIAF/bioaffinity-technologies-to-participate-in-the-h-c-wainwright-28th-annual-global-633bc2d2) — Source: bioAffinity Technologies, Inc.
- 2026-09-03 10:00 EST — BDSX — [Biodesix to Participate in Upcoming Investor Conferences](https://biopharmsignal.com/news/BDSX/biodesix-to-participate-in-upcoming-investor-conferences-23d65bf2) — Source: Biodesix
- 2026-09-01 12:31 EST — INBS — [Intelligent Bio Solutions Achieves Above 98% Accuracy in Method Comparison Study, Supporting Planned 2026 FDA 510(k) Submission](https://biopharmsignal.com/news/INBS/intelligent-bio-solutions-achieves-above-98-accuracy-in-method-comparison-study--03c9a529) — Source: Intelligent Bio Solutions
- 2026-09-01 12:30 EST — INBS — [Intelligent Bio Solutions Announces Private Placement of up to $15 Million to a Single Existing Institutional Investor Priced At-the-Market Under Nasdaq Rules](https://biopharmsignal.com/news/INBS/intelligent-bio-solutions-announces-private-placement-of-up-to-15-million-to-a-s-f2d68af0) — Source: Intelligent Bio Solutions
- 2026-09-01 12:00 EST — BIAF — [bioAffinity Technologies Advances CyPath® Lung for Surveillance of Lung Cancer Survivors](https://biopharmsignal.com/news/BIAF/bioaffinity-technologies-advances-cypath-lung-for-surveillance-of-lung-cancer-su-46fe80c1) — Source: bioAffinity Technologies, Inc.
- 2026-08-25 18:06 EST — DGX — [Humanity Brings Biological Age Analysis to the U.S. Through questhealth.com](https://biopharmsignal.com/news/DGX/humanity-brings-biological-age-analysis-to-the-u-s-through-questhealth-com-6503d9eb) — Source: Quest Diagnostics
- 2026-08-25 13:30 EST — DGX — [Quest Diagnostics to Speak at the Baird 2026 Global Healthcare Conference](https://biopharmsignal.com/news/DGX/quest-diagnostics-to-speak-at-the-baird-2026-global-healthcare-conference-aed53643) — Source: Quest Diagnostics
- 2026-08-25 12:00 EST — SERA — [1 in 10 U.S. Babies Are Born Too Early. A Leading OB-GYN Says Most Mothers Can Learn Their Risk by Week 21, and Do Something About It](https://biopharmsignal.com/news/SERA/1-in-10-u-s-babies-are-born-too-early-a-leading-ob-gyn-says-most-mothers-can-lea-3ce74ffe) — Source: Sera Prognostics
- 2026-08-24 13:00 EST — DGX — [Quest Diagnostics to Speak at the Morgan Stanley 24th Annual Global Healthcare Conference](https://biopharmsignal.com/news/DGX/quest-diagnostics-to-speak-at-the-morgan-stanley-24th-annual-global-healthcare-c-8a442659) — Source: Quest Diagnostics
- 2026-08-24 11:24 EST — DGX — [Quest Diagnostics to Offer FDA-Cleared Roche pTau217 Blood Test to Assess Alzheimer's Disease Pathology](https://biopharmsignal.com/news/DGX/quest-diagnostics-to-offer-fda-cleared-roche-ptau217-blood-test-to-assess-alzhei-364b2a60) — Source: Quest Diagnostics
- 2026-08-20 12:00 EST — BIAF — [bioAffinity Technologies Announces 1-for-15 Reverse Stock Split Effective at the Open of Trading on August 24, 2026](https://biopharmsignal.com/news/BIAF/bioaffinity-technologies-announces-1-for-15-reverse-stock-split-effective-at-the-18f7b0b7) — Source: bioAffinity Technologies, Inc.
- 2026-08-19 20:30 EST — SERA — [SERA PROGNOSTICS APPOINTS SCOTT GLEASON CHIEF FINANCIAL OFFICER](https://biopharmsignal.com/news/SERA/sera-prognostics-appoints-scott-gleason-chief-financial-officer-4701ba99) — Source: Sera Prognostics
- 2026-08-19 12:30 EST — INBS — [Intelligent Bio Solutions Reports Fiscal 2026 Full-Year Revenue Growth of 38% Year-over-Year, Driven by Reader Installed Base and High-Margin Cartridge Growth](https://biopharmsignal.com/news/INBS/intelligent-bio-solutions-reports-fiscal-2026-full-year-revenue-growth-of-38-yea-fbc9f088) — Source: Intelligent Bio Solutions
- 2026-08-18 12:00 EST — BIAF — [bioAffinity Technologies and AvMEDICAL Announce Nationwide Federal Healthcare Distribution Agreement for CyPath® Lung](https://biopharmsignal.com/news/BIAF/bioaffinity-technologies-and-avmedical-announce-nationwide-federal-healthcare-di-10f92d5f) — Source: bioAffinity Technologies, Inc.
- 2026-08-17 12:30 EST — INBS — [Intelligent Bio Solutions Strengthens Quality Management Credentials with ISO Recertification](https://biopharmsignal.com/news/INBS/intelligent-bio-solutions-strengthens-quality-management-credentials-with-iso-re-26b08a12) — Source: Intelligent Bio Solutions
- 2026-08-14 15:07 EST — BIAF — [bioAffinity Technologies Announces Closing of $4M Private Placement Offering Priced At-the-Market Under Nasdaq Rules](https://biopharmsignal.com/news/BIAF/bioaffinity-technologies-announces-closing-of-4m-private-placement-offering-pric-df8f2f58) — Source: bioAffinity Technologies, Inc.
- 2026-08-13 20:00 EST — MDXH — [Mdxhealth Reports Second Quarter 2026 Financial Results](https://biopharmsignal.com/news/MDXH/mdxhealth-reports-second-quarter-2026-financial-results-5edfb69f) — Source: MDxHealth
- 2026-08-13 13:15 EST — BRLI — [OPKO Health Expands Strategic Relationship with HealthCare Royalty Through $125 Million Notes Issuance Secured by Mazdutide Royalty Interests](https://biopharmsignal.com/news/BRLI/opko-health-expands-strategic-relationship-with-healthcare-royalty-through-125-m-ea1a2899) — Source: Bio-Reference Laboratories
- 2026-08-13 13:07 EST — BIAF — [bioAffinity Technologies Announces Pricing of $4M Private Placement Offering Priced At-the-Market Under Nasdaq Rules](https://biopharmsignal.com/news/BIAF/bioaffinity-technologies-announces-pricing-of-4m-private-placement-offering-pric-f3a301bc) — Source: bioAffinity Technologies, Inc.
- 2026-08-13 12:00 EST — LUCD — [Lucid Diagnostics Provides Business Update and Reports Second Quarter 2026 Financial Results](https://biopharmsignal.com/news/LUCD/lucid-diagnostics-provides-business-update-and-reports-second-quarter-2026-finan-ea9917e9) — Source: Lucid Diagnostics

## Companies

- [AXDX](https://biopharmsignal.com/company/AXDX) — Accelerate Diagnostics
- [ANPC](https://biopharmsignal.com/company/ANPC) — AnPac Bio-Medical Science
- [AWH](https://biopharmsignal.com/company/AWH) — Aspira Women's Health
- [ATOS](https://biopharmsignal.com/company/ATOS) — Atossa Therapeutics, Inc.
- [BRLI](https://biopharmsignal.com/company/BRLI) — Bio-Reference Laboratories
- [BIAF](https://biopharmsignal.com/company/BIAF) — bioAffinity Technologies, Inc.
- [BDSX](https://biopharmsignal.com/company/BDSX) — Biodesix
- [BJDX](https://biopharmsignal.com/company/BJDX) — Bluejay Diagnostics
- [CNTG](https://biopharmsignal.com/company/CNTG) — Centogene
- [HLTH](https://biopharmsignal.com/company/HLTH) — Cue Health
- [DECI](https://biopharmsignal.com/company/DECI) — Decipher Biosciences
- [DMTK](https://biopharmsignal.com/company/DMTK) — DermTech
- [ESMC](https://biopharmsignal.com/company/ESMC) — Escalon Medical
- [EXAS](https://biopharmsignal.com/company/EXAS) — Exact Sciences
- [XGN](https://biopharmsignal.com/company/XGN) — Exagen
- [FLGT](https://biopharmsignal.com/company/FLGT) — Fulgent Genetics, Inc.
- [WGS](https://biopharmsignal.com/company/WGS) — GeneDx
- [HNSA](https://biopharmsignal.com/company/HNSA) — Hansa Biopharma AB
- [HTGM](https://biopharmsignal.com/company/HTGM) — HTG Molecular Diagnostics
- [INBS](https://biopharmsignal.com/company/INBS) — Intelligent Bio Solutions
- [LNTH](https://biopharmsignal.com/company/LNTH) — Lantheus Holdings, Inc.
- [LUCD](https://biopharmsignal.com/company/LUCD) — Lucid Diagnostics
- [LMDXF](https://biopharmsignal.com/company/LMDXF) — LumiraDx
- [MYNZ](https://biopharmsignal.com/company/MYNZ) — Mainz Biomed
- [MDXH](https://biopharmsignal.com/company/MDXH) — MDxHealth
- [NTRA](https://biopharmsignal.com/company/NTRA) — Natera
- [NEOG](https://biopharmsignal.com/company/NEOG) — Neogen Corp.
- [OPGN](https://biopharmsignal.com/company/OPGN) — OpGen
- [OSUR](https://biopharmsignal.com/company/OSUR) — OraSure Technologies, Inc.
- [RVTY](https://biopharmsignal.com/company/RVTY) — PerkinElmer
- [QGEN](https://biopharmsignal.com/company/QGEN) — Qiagen N.V.
- [DGX](https://biopharmsignal.com/company/DGX) — Quest Diagnostics
- [SERA](https://biopharmsignal.com/company/SERA) — Sera Prognostics
- [TTOO](https://biopharmsignal.com/company/TTOO) — T2 Biosystems
- [TLIS](https://biopharmsignal.com/company/TLIS) — Talis Biomedical Corp
- [TMO](https://biopharmsignal.com/company/TMO) — Thermo Fisher Scientific Inc
- [VCYT](https://biopharmsignal.com/company/VCYT) — Veracyte
- [VRAX](https://biopharmsignal.com/company/VRAX) — Virax Biolabs